Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: prospective multicentre preSINO trial
Yang Yang(Zhengzhou University), Zhigang Li(National Institutes of Health), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Yin‐Kai Chao(Chang Gung University), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Xing Gao(Soochow University), Simon Law(Inserm), Ben M. Eyck(Erasmus MC Cancer Institute), Yuchen Han(China Medical University), Hong Zhang(Shanghai Jiao Tong University), Zhichao Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Liu(Shanghai Jiao Tong University), Berend J. van der Wilk(Erasmus MC Cancer Institute), Jinchen Shao(Shanghai Jiao Tong University), Yhi Wong(University of Hong Kong)
Cited by 11
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
|Nature Genetics|2014|1.1k
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
|Nature Genetics|2009|788
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788